Bausch + Lomb Corp (BLCO) - Total Liabilities
Based on the latest financial reports, Bausch + Lomb Corp (BLCO) has total liabilities worth CA$7.33 Billion CAD (≈ $5.30 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BLCO current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Bausch + Lomb Corp - Total Liabilities Trend (2019–2024)
This chart illustrates how Bausch + Lomb Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Bausch + Lomb Corp asset portfolio.
Bausch + Lomb Corp Competitors by Total Liabilities
The table below lists competitors of Bausch + Lomb Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Soochow Securities Co Ltd
SHG:601555
|
China | CN¥174.12 Billion |
|
Loar Holdings Inc.
NYSE:LOAR
|
USA | $1.12 Billion |
|
Arcosa Inc
NYSE:ACA
|
USA | $2.26 Billion |
|
Yantai Moon Co Ltd
SHE:000811
|
China | CN¥6.01 Billion |
|
Hyundai Mipo Dockyard
KO:010620
|
Korea | ₩2.95 Trillion |
|
Zheshang Securities Co Ltd
SHG:601878
|
China | CN¥223.62 Billion |
|
Trade Desk Inc
NASDAQ:TTD
|
USA | $3.67 Billion |
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥851.65 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Bausch + Lomb Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Bausch + Lomb Corp (BLCO) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bausch + Lomb Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bausch + Lomb Corp (2019–2024)
The table below shows the annual total liabilities of Bausch + Lomb Corp from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$6.92 Billion ≈ $5.01 Billion |
+6.18% |
| 2023-12-31 | CA$6.52 Billion ≈ $4.72 Billion |
+61.32% |
| 2022-12-31 | CA$4.04 Billion ≈ $2.92 Billion |
+184.52% |
| 2021-12-31 | CA$1.42 Billion ≈ $1.03 Billion |
+11.19% |
| 2020-12-31 | CA$1.28 Billion ≈ $924.49 Million |
-11.00% |
| 2019-12-31 | CA$1.44 Billion ≈ $1.04 Billion |
-- |
About Bausch + Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily d… Read more